(CSL) Carlisle Companies - Ratings and Ratios
Roofing Solutions, Insulation, Weatherproofing, Sealants, HVAC Products
CSL EPS (Earnings per Share)
CSL Revenue
Description: CSL Carlisle Companies
Carlisle Companies Incorporated is a leading manufacturer and supplier of building envelope products and solutions, operating globally through two main segments: Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT). CCM offers a range of single-ply roofing solutions, engineered metal roofing, and wall panel systems, while CWT provides waterproofing, air/vapor barriers, and other premium polyurethane products.
To further analyze the companys performance, we can examine key performance indicators (KPIs) such as revenue growth, operating margin, and return on equity (ROE). With a ROE of 66.32%, Carlisle Companies Incorporated demonstrates a strong ability to generate profits from shareholder equity. Additionally, the companys diverse product portfolio and global presence contribute to its competitive advantage.
From a valuation perspective, the companys price-to-earnings (P/E) ratio of 22.17 and forward P/E of 17.89 indicate a relatively stable valuation. To assess the companys growth prospects, we can examine metrics such as earnings per share (EPS) growth and revenue growth. A thorough analysis of these KPIs can provide insights into the companys ability to sustain its growth momentum.
Carlisle Companies Incorporateds strong brand portfolio, including Carlisle SynTec, Versico, and WeatherBond, among others, is a significant factor in its market position. The companys commitment to innovation and customer satisfaction is reflected in its diverse product offerings and global distribution network. By examining the companys financials and operational metrics, we can gain a deeper understanding of its strengths and weaknesses.
CSL Stock Overview
Market Cap in USD | 16,724m |
Sub-Industry | Industrial Conglomerates |
IPO / Inception | 1987-11-05 |
CSL Stock Ratings
Growth Rating | 49.5 |
Fundamental | 79.3% |
Dividend Rating | 65.6 |
Rel. Strength | -21.1 |
Analysts | 4.00 of 5 |
Fair Price Momentum | 407.20 USD |
Fair Price DCF | 541.48 USD |
CSL Dividends
Dividend Yield 12m | 1.04% |
Yield on Cost 5y | 3.33% |
Annual Growth 5y | 12.54% |
Payout Consistency | 100.0% |
Payout Ratio | 20.4% |
CSL Growth Ratios
Growth Correlation 3m | 5.8% |
Growth Correlation 12m | -49% |
Growth Correlation 5y | 91.4% |
CAGR 5y | 25.98% |
CAGR/Max DD 5y | 0.75 |
Sharpe Ratio 12m | -1.20 |
Alpha | -24.48 |
Beta | 1.107 |
Volatility | 34.42% |
Current Volume | 393.8k |
Average Volume 20d | 436.4k |
Stop Loss | 365.8 (-4.1%) |
Signal | -2.08 |
Piotroski VR‑10 (Strict, 0-10) 9.0
Net Income (806.2m TTM) > 0 and > 6% of Revenue (6% = 300.1m TTM) |
FCFTA 0.16 (>2.0%) and ΔFCFTA -0.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 16.59% (prev 41.80%; Δ -25.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.18 (>3.0%) and CFO 972.3m > Net Income 806.2m (YES >=105%, WARN >=100%) |
Net Debt (1.82b) to EBITDA (1.18b) ratio: 1.55 <= 3.0 (WARN <= 3.5) |
Current Ratio 2.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (44.0m) change vs 12m ago -8.14% (target <= -2.0% for YES) |
Gross Margin 40.89% (prev 37.56%; Δ 3.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 81.68% (prev 73.34%; Δ 8.34pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 16.63 (EBITDA TTM 1.18b / Interest Expense TTM 65.4m) >= 6 (WARN >= 3) |
Altman Z'' 8.55
(A) 0.15 = (Total Current Assets 1.53b - Total Current Liabilities 697.1m) / Total Assets 5.52b |
(B) 1.28 = Retained Earnings (Balance) 7.08b / Total Assets 5.52b |
warn (B) unusual magnitude: 1.28 — check mapping/units |
(C) 0.18 = EBIT TTM 1.09b / Avg Total Assets 6.12b |
(D) 2.09 = Book Value of Equity 7.09b / Total Liabilities 3.40b |
Total Rating: 8.55 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.29
1. Piotroski 9.0pt = 4.0 |
2. FCF Yield 4.63% = 2.31 |
3. FCF Margin 17.17% = 4.29 |
4. Debt/Equity 0.89 = 2.12 |
5. Debt/Ebitda 1.61 = 0.76 |
6. ROIC - WACC 10.26% = 12.50 |
7. RoE 33.90% = 2.50 |
8. Rev. Trend -6.38% = -0.32 |
9. Rev. CAGR -1.07% = -0.18 |
10. EPS Trend 26.79% = 0.67 |
11. EPS CAGR 6.28% = 0.63 |
What is the price of CSL shares?
Over the past week, the price has changed by +4.05%, over one month by -4.31%, over three months by -4.62% and over the past year by -5.24%.
Is Carlisle Companies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSL is around 407.20 USD . This means that CSL is currently overvalued and has a potential downside of 6.76%.
Is CSL a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CSL price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 425.6 | 11.6% |
Analysts Target Price | 436.7 | 14.5% |
ValueRay Target Price | 456.2 | 19.6% |
Last update: 2025-08-15 15:21
CSL Fundamental Data Overview
CCE Cash And Equivalents = 68.4m USD (last quarter)
P/E Trailing = 21.8792
P/E Forward = 19.1939
P/S = 3.3436
P/B = 8.0433
P/EG = 1.2788
Beta = 1.049
Revenue TTM = 5.00b USD
EBIT TTM = 1.09b USD
EBITDA TTM = 1.18b USD
Long Term Debt = 1.89b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 1.89b USD (Calculated: Short Term 0.0 + Long Term 1.89b)
Net Debt = 1.82b USD (from netDebt column, last quarter)
Enterprise Value = 18.55b USD (16.72b + Debt 1.89b - CCE 68.4m)
Interest Coverage Ratio = 16.63 (Ebit TTM 1.09b / Interest Expense TTM 65.4m)
FCF Yield = 4.63% (FCF TTM 858.6m / Enterprise Value 18.55b)
FCF Margin = 17.17% (FCF TTM 858.6m / Revenue TTM 5.00b)
Net Margin = 16.12% (Net Income TTM 806.2m / Revenue TTM 5.00b)
Gross Margin = 40.89% ((Revenue TTM 5.00b - Cost of Revenue TTM 2.96b) / Revenue TTM)
Tobins Q-Ratio = 2.62 (Enterprise Value 18.55b / Book Value Of Equity 7.09b)
Interest Expense / Debt = 0.78% (Interest Expense 14.7m / Debt 1.89b)
Taxrate = 22.13% (from yearly Income Tax Expense: 245.8m / 1.11b)
NOPAT = 847.1m (EBIT 1.09b * (1 - 22.13%))
Current Ratio = 2.19 (Total Current Assets 1.53b / Total Current Liabilities 697.1m)
Debt / Equity = 0.89 (Debt 1.89b / last Quarter total Stockholder Equity 2.12b)
Debt / EBITDA = 1.61 (Net Debt 1.82b / EBITDA 1.18b)
Debt / FCF = 2.20 (Debt 1.89b / FCF TTM 858.6m)
Total Stockholder Equity = 2.38b (last 4 quarters mean)
RoA = 14.61% (Net Income 806.2m, Total Assets 5.52b )
RoE = 33.90% (Net Income TTM 806.2m / Total Stockholder Equity 2.38b)
RoCE = 25.48% (Ebit 1.09b / (Equity 2.38b + L.T.Debt 1.89b))
RoIC = 19.39% (NOPAT 847.1m / Invested Capital 4.37b)
WACC = 9.13% (E(16.72b)/V(18.62b) * Re(10.09%)) + (D(1.89b)/V(18.62b) * Rd(0.78%) * (1-Tc(0.22)))
Shares Correlation 5-Years: -100.0 | Cagr: -3.69%
Discount Rate = 10.09% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.96% ; FCFE base≈939.8m ; Y1≈1.15b ; Y5≈1.93b
Fair Price DCF = 541.5 (DCF Value 23.15b / Shares Outstanding 42.8m; 5y FCF grow 24.04% → 3.0% )
Revenue Correlation: -6.38 | Revenue CAGR: -1.07%
Revenue Growth Correlation: 30.08%
EPS Correlation: 26.79 | EPS CAGR: 6.28%
EPS Growth Correlation: -35.85%
Additional Sources for CSL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle